Hatch Biofund
Overview
Hatch Biofund is a life sciences venture capital firm that provides early-stage capital to private companies developing therapeutics and vaccines for human use.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Optimeos Life Sciences | May 2026 | Seed Round | Co-investor |
| Ladder Bio | Nov 2025 | Seed | Co-investor |
| Hula Therapeutics | Jul 2024 | Seed | Lead |
| Vittoria Biotherapeutics | Nov 2024 | Private Financing Extension | Co-investor |
| Latus Bio | May 2026 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Hatch Biofund based?
Hatch Biofund is headquartered in Doylestown, Pennsylvania, United States.
When was Hatch Biofund founded?
Hatch Biofund was founded in 2018.
How many portfolio companies does Hatch Biofund have?
Hatch Biofund has 5 portfolio companies in Caplight's dataset.
What are some companies in Hatch Biofund's portfolio?
Portfolio companies visible on Caplight include Optimeos Life Sciences, Ladder Bio, Hula Therapeutics, Vittoria Biotherapeutics, Latus Bio.
What was Hatch Biofund's most recent investment shown here?
Hatch Biofund's most recent investment in this portfolio sample was in Optimeos Life Sciences in 2026.
What sectors does Hatch Biofund focus on?
Hatch Biofund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Hatch Biofund focus on?
Hatch Biofund typically invests at the Early stage.